For patients with schizophrenia and breast cancer, initial radical surgery without adjuvant radiation therapy may be preferred.
Pre-existing diabetes increases risk of total mortality among women with breast cancer.
A recent study has found a modest association between smoking and breast cancer risk in women.
When breast and colorectal cancers occur in children, the diseases are aggressive.
Generic aromatase inhibitors improved treatment adherence by 50% in hormone receptor-positive breast cancer.
Relaxation and yoga are the best complementary therapies for the treatment of breast cancer.
Recent trial investigated the impact of a yoga intervention on fatigue and inflammation among breast cancer survivors.
Children who underwent chest radiation for the treatment of Wilms tumor may have an increased risk for developing breast cancer.
Herceptin in addition to chemotherapy boosts survival, reduces risk of cancer recurrence
Findings in comparative economic analysis of patients with node-negative breast cancer showed the 70-gene signature is unlikely to be cost-effective for guiding adjuvant chemotherapy decision making.
A change in diagnosis resulted from PET/CT imaging of patients who were younger than 40 years with an initial diagnosis of stage I-III breast cancer, according to a retrospective analysis.
'Extra Help' program allows more women of varying racial and ethnic backgrounds to continue their hormone therapy.
Patients with HER2-positive breast cancer that has metastasized demonstrate longer survival outcomes if treated with a combination of pertuzumab, trastuzumab, and chemotherapy.
A healthy lifestyle may improve survival of patients with breast cancer.
Women treated for breast cancer improved their quality of life after participating in post-treatment intervention.
Human epidermal growth factor receptor 2 (HER2) mutations may offer an important treatment target in a subset of patients with non-small cell lung cancer.
Breast cancer experts world-wide have urged for continued high quality research on advanced breast cancer.
The use of trastuzumab (Herceptin) as the standard-of-care treatment for HER2-positive breast cancer has been supported by the Adjuvant Lapatinib and/or Trastuzumab Treatment Optimization (ALTTO) study.
Researchers have successfully tested a new tool that will help surgeons better distinguish cancerous breast tissue from normal tissue, which should lower the mount of repeat procedures needed.
Referrals for genetic counseling and testing for breast cancer risk more than doubled across the United Kingdom after Angelina Jolie's May 2013 announcement she tested positive for BRCA1 gene mutation and underwent a double mastectomy.
Oral bisphosphonates to treat osteoporosis may also slow skeletal metastases caused by breast cancer.
[Breast Cancer (Auckl)] Breast positioning is the key factor affecting a mammogram. Done properly, correct positioning maximizes the amount of breast tissue being imaged, eliminates most of the artifacts, and increases sensitivity of the mammogram.
Scientists are now developing an "electronic skin" that will aid in the detection of breast masses.
Exposure to dim light at night may make breast tumors resistant to chemotherapy
Despite its acceptance as standard of care neary 25 years ago, barriers still exist that preclude patients from receiving breast conserving therapy (BCT), according to research presented at the ASCO 2014 Breast Cancer Symposium.
Adding carboplatin and/or bevacizumab to the standard treatment regimen significantly improved pathologic complete response rates in patients with triple-negative breast cancer, according to a new phase 2 study.
Drug should remain standard of care for HER2-positive tumors, according to new research.
A recent study found no link between bra wearing and increased breast cancer risk among postmenopausal women.
An experimental regimen of once-weekly breast irradiation after lumpectomy provides more convenience to patients at less expense, and results in better completion rates of prescribed radiation treatment.
Is there a good reason to mix nab-paclitaxel (Abraxane) with warm (not cool) normal saline when reconstituting?
A new immunotherapy vaccine candidate for breast cancer shows promise, having reduced recurrence rate by more than fifty percent.
Women whose skirt size increases one size every 10 years have a 33% increased risk for developing breast cancer.
The experimental drug nintedanib, in combination with standard paclitaxel chemotherapy, caused a total remission of tumors in half of patients with early stage HER2-negative breast cancer.
Most women who chose to undergo double mastectomies despite having cancer in only one breast are content with their choice.
Mammograms for those aged 69 to 75 could result in over-treatment, researchers caution.
Scientists have developed a tool to distinguish each breast cancer subtype, research that could improve treatments and targeting of treatments for the disease.
Breast cancer cells can lay the groundwork for their own metastasis throughout the body by coaxing cells within lymphatic vessels to send out tumor-welcoming signals.
The BluePrint genomic test provides more accurate information about the molecular subtype of a specific breast cancer, compared with the use of conventional IHC-FISH pathology tests, according to a new study.
One-third of women who are given information about the potential for over-diagnosis through the National Health Services (NHS) breast screening program may not completely understand the risks involved.
Screening women for breast cancer up to age 75 may lead to overdiagnosis and overtreatment.
Postmenopausal women with a diverse gut microbiome have higher levels of estrogen metabolites.
The percentage of women that underwent a double mastectomy increased substantially between 1998 and 2011, even though the procedure was not associated with a lower risk of death than breast-conserving surgery plus radiation.
Women with severe disabilities and multiple chronic conditions are screened for breast cancer less often than women with no disabilities or no chronic conditions.
GP2, a novel immunotherapy, has demonstrated a reduction in recurrence in patients with breast cancer.
Researchers have developed a new integrated approach to identify the genetic drivers of cancer, uncovering eight genes necessary for cell proliferation in breast cancer.
Study raises questions about the effect of soy's estrogen-like properties.
Women overdue for mammogram respond better to postcard plus reminder letter from family physician.
A protein named p66ShcA shows promise as a biomarker to identify breast cancers with poor prognoses, according to new research.
Evidence-based recommendations have been developed for chemotherapy and targeted therapy for women with HER2-negative advanced breast cancer.
Celebrity story helped double rates of genetic testing in following six months at one cancer center.
Women with breast cancer who have a double mastectomy are at higher risk of certain complications than those who have a single mastectomy, though the overall complication rate associated with breast cancer surgery is small.
Wearing bras does not increase a woman's risk for developing breast cancer.
This fact sheet examines the potential pros and cons of surgery as a means to reduce breast cancer risk.
Following a mastectomy, less than 42% of women underwent breast reconstruction, and the factors associated with foregoing reconstruction included being black, being less educated, and being older.
Survey of women with breast cancer explores factors in the decision to remove a healthy breast as a measure to prevent breast cancer.
Bilateral mastectomy-linked mortality rates are up for women diagnosed with stage 0 to III breast cancer.
Despite an increase in double mastectomy for early-stage breast cancer, the procedure does not reduce the risk of mortality.
A biomarker strongly linked to basal-like breast cancer has been identified.
This recently published study found strong evidence linking physical exercise to a lower rate of breast cancer in African American women, a group in which previous evidence has been lacking.
Osteoporosis drugs known as bisphosphonates may not protect women from breast cancer as had been thought, according to a new study.
Inclusion of endogenous hormones in prediction models improves prediction of invasive breast cancer risk in postmenopausal women, according to a study.
Postmenopausal women who in the past 4 years had undertaken regular physical activity equivalent to at least 4 hours of walking per week had a lower risk for invasive breast cancer compared with women who exercised less
The PALB2 gene is potentially one of the most important genes associated with breast cancer after the BRCA1/2 genes.
Recurrence of hormone-related breast cancer was reduced by 50% in overweight and obese women who regularly used aspirin or other nonsteroidal anti-inflammatory drugs (NSAIDs), according to newly published data.
Dasatinib shows promise for treating skin, breast and several other cancers.
MRI detects 18.1 additional cancers after negative findings with mammography and ultrasonography per 1,000 women.
Data from two randomized controlled trials suggest that bisphosphonate use does not protect against postmenopausal breast cancer, according to research.
In overweight women, aspirin or other drugs might make certain breast cancers more treatable.
Writing down fears, emotions, and the benefits of a cancer diagnosis may improve health outcomes for Asian American survivors of breast cancer, according to a new study. The research investigated methods of reducing the psychological burden among minority patients, particularly among breast cancer survivors.
New research suggests that cancer would be more accurately diagnosed in 1 of every 10 patients if their tumors were defined by cellular and molecular criteria rather than by the tissues in which they originated, and that this information, in turn, could lead to more appropriate treatments.
Mammography-detected breast cancer is associated with a shift to earlier stage diagnosis in older women, subsequently reducing the rate of more advanced, difficult-to-treat cases. Researchers said the findings lend support to regular mammography screening in women age 75 years and older.
Mutations in PALB2 and germline mutations in the multiple endocrine neoplasia type 1 (MEN1) tumor-suppressor gene causing MEN1 correlate with increased breast cancer risk, according to two studies.
Electroacupuncture (EA) produces significant improvements in fatigue, anxiety, and depression in as little as 8 weeks for patients with early stage breast cancer experiencing joint pain related to the use of aromatase inhibitors to treat breast cancer.
Older women intent on keeping breast cancer at bay may want to start and maintain a regular exercise regimen.
Breast cancer survival has been found to be better in women whose cancer was detected by mammography.
Electroacupuncture may reduce comorbid symptoms of pain in women with breast cancer who have aromatase inhibitor-related arthralgia, according to research.
Research published in the Journal of Biomedicine and Biotechnology suggests that ginger may be a promising breast cancer treatment.
Women who recently used birth control pills containing high-dose estrogen and a few other formulations had an increased risk for breast cancer, whereas women using some other formulations did not, according to recent data.
A gel form of tamoxifen applied to the breasts of women with noninvasive breast cancer reduced the growth of cancer cells to the same degree as the drug taken in oral form but with fewer side effects.
According to a study published in Radiology, women over 75, a population not typically included in mammography screening effectiveness studies, may benefit from mammograms.
A new molecular analysis tool accurately detected the level of an important target for immunotherapy in early stage breast cancers.
A new study demonstrated that writing about emotionally difficult events, such as a cancer diagnosis, might improve outcomes for some breast cancer survivors.
Keeping a light on at night can suppress the body's production of a hormone called melatonin, possibly reducing the effectiveness of the breast-cancer drug tamoxifen, a study suggests.
For rats bearing human breast tumors, exposure to dim light at night made the tumors resistant to the breast cancer drug tamoxifen, according to recently published data.
A team of researchers from Boston University School of Medicine sought to determine the impact of patient navigators on the care of low-income and African-American women with breast cancer.
Use of electroacupuncture produces significant improvements in fatigue, anxiety, and depression in as little as 8 weeks for patients with early stage breast cancer patients experiencing joint pain related to the use of AIs to treat breast cancer.
A new study has identified three genetic changes in East Asian women linked to an increased risk of breast cancer.
Breast cancer screening is once again controversial. In this editorial, the author discusses new research demonstrating the effectiveness of an MRI imaging technique called first postcontrast subtracted T1-weighted image (FAST).
What is the preferred delivery protocol for breast cancer adjuvant bisphosphonates?
A study of people who were adopted identified genetics as the dominant risk factor in familial breast, prostate, and colorectal cancers.
Breast cancer screening costs for Medicare patients skyrocketed between 2001 and 2009, but the increase did not lead to earlier detection of new breast cancer cases, according to a study.
A new study suggests a safe and effective role for natural steroid hormones in treating postmenopausal breast cancer, with fewer detrimental side effects and improved health profile than with standard antihormone therapies.
A simple blood test is currently in development that could help predict the likelihood of a woman developing breast cancer, even in the absence of a high-risk BRCA1 gene mutation, according to new research.
Researchers have identified genes that may help predict whether a patient with estrogen receptor (ER)-positive breast cancer is likely to benefit from tamoxifen therapy.
Circulating tumor cells captured with a microchip-based device can be cultured to establish cell lines for genetic analysis and drug testing.
Current studies indicate that the levels of parabens used in cosmetics are safe (typical levels are 0.1% to 0.3%); however, many believe a relationship to cancer exists, particularly breast cancer. The furor came about after a 2004 study reported finding parabens in the breast tissue of 20 women.
New findings paint a relatively optimistic picture of women's chances of surviving a subset of breast cancers that have spread to the chest wall or skin, but not beyond.
The era of personalized medicine for breast cancer may be just around the corner, thanks to recent advances by USC Stem Cell researcher Min Yu and scientists at Massachusetts General Hospital and Harvard Medical School.
Researchers have created a microchip device that can capture circulating tumor cells, in order to track ongoing genetic mutation within a tumor.
Using an innovative tool that captures heretofore hidden ways that cells are regulated, scientists have identified a protein that makes breast cancer cells more likely to metastasize.
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|